Market Closed -
Japan Exchange
07:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
679
JPY
|
-0.29%
|
|
-0.73%
|
-23.02%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,994
|
4,808
|
3,749
|
4,110
|
3,404
|
2,520
|
Enterprise Value (EV)
1 |
8,862
|
7,458
|
6,370
|
6,734
|
5,620
|
4,715
|
P/E ratio
|
73.7
x
|
38.3
x
|
98.3
x
|
54.8
x
|
20.1
x
|
15.9
x
|
Yield
|
0.72%
|
0.91%
|
0.35%
|
0.54%
|
1.3%
|
1.75%
|
Capitalization / Revenue
|
2.25
x
|
1.63
x
|
1.26
x
|
1.44
x
|
1.1
x
|
0.85
x
|
EV / Revenue
|
3.32
x
|
2.52
x
|
2.14
x
|
2.36
x
|
1.82
x
|
1.59
x
|
EV / EBITDA
|
21
x
|
13.9
x
|
12.6
x
|
14.4
x
|
9.56
x
|
10.5
x
|
EV / FCF
|
-11.9
x
|
-55.1
x
|
1,132
x
|
-141
x
|
36.9
x
|
857
x
|
FCF Yield
|
-8.43%
|
-1.81%
|
0.09%
|
-0.71%
|
2.71%
|
0.12%
|
Price to Book
|
3.85
x
|
2.9
x
|
2.3
x
|
2.39
x
|
1.79
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
4,337
|
4,355
|
4,401
|
4,400
|
4,421
|
4,421
|
Reference price
2 |
1,382
|
1,104
|
852.0
|
934.0
|
770.0
|
570.0
|
Announcement Date
|
22/06/18
|
21/06/19
|
24/06/20
|
23/06/21
|
27/06/22
|
22/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,669
|
2,955
|
2,977
|
2,855
|
3,086
|
2,961
|
EBITDA
1 |
423
|
537
|
505
|
467
|
588
|
450
|
EBIT
1 |
142
|
208
|
130
|
140
|
312
|
163
|
Operating Margin
|
5.32%
|
7.04%
|
4.37%
|
4.9%
|
10.11%
|
5.5%
|
Earnings before Tax (EBT)
1 |
106
|
157
|
64
|
111
|
254
|
197
|
Net income
1 |
82
|
127
|
38
|
75
|
169
|
158
|
Net margin
|
3.07%
|
4.3%
|
1.28%
|
2.63%
|
5.48%
|
5.34%
|
EPS
2 |
18.74
|
28.79
|
8.665
|
17.04
|
38.26
|
35.74
|
Free Cash Flow
1 |
-747.1
|
-135.2
|
5.625
|
-47.75
|
152.4
|
5.5
|
FCF margin
|
-27.99%
|
-4.58%
|
0.19%
|
-1.67%
|
4.94%
|
0.19%
|
FCF Conversion (EBITDA)
|
-
|
-
|
1.11%
|
-
|
25.91%
|
1.22%
|
FCF Conversion (Net income)
|
-
|
-
|
14.8%
|
-
|
90.16%
|
3.48%
|
Dividend per Share
2 |
10.00
|
10.00
|
3.000
|
5.000
|
10.00
|
10.00
|
Announcement Date
|
22/06/18
|
21/06/19
|
24/06/20
|
23/06/21
|
27/06/22
|
22/06/23
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
1,543
|
1,353
|
1,621
|
733
|
752
|
1,442
|
770
|
864
|
1,699
|
751
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
96
|
60
|
177
|
92
|
57
|
95
|
56
|
89
|
127
|
-14
|
Operating Margin
|
6.22%
|
4.43%
|
10.92%
|
12.55%
|
7.58%
|
6.59%
|
7.27%
|
10.3%
|
7.47%
|
-1.86%
|
Earnings before Tax (EBT)
1 |
86
|
50
|
162
|
64
|
69
|
134
|
44
|
102
|
141
|
-16
|
Net income
1 |
62
|
38
|
111
|
43
|
54
|
98
|
34
|
76
|
104
|
-17
|
Net margin
|
4.02%
|
2.81%
|
6.85%
|
5.87%
|
7.18%
|
6.8%
|
4.42%
|
8.8%
|
6.12%
|
-2.26%
|
EPS
2 |
14.23
|
8.720
|
25.29
|
9.640
|
12.39
|
22.38
|
7.620
|
17.28
|
23.53
|
-3.640
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/11/19
|
06/11/20
|
05/11/21
|
04/02/22
|
05/08/22
|
04/11/22
|
03/02/23
|
04/08/23
|
08/11/23
|
07/02/24
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,868
|
2,650
|
2,621
|
2,624
|
2,216
|
2,195
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.78
x
|
4.935
x
|
5.19
x
|
5.619
x
|
3.769
x
|
4.878
x
|
Free Cash Flow
1 |
-747
|
-135
|
5.63
|
-47.8
|
152
|
5.5
|
ROE (net income / shareholders' equity)
|
5.38%
|
7.88%
|
2.31%
|
4.48%
|
9.33%
|
8.07%
|
ROA (Net income/ Total Assets)
|
1.55%
|
2.31%
|
1.52%
|
1.58%
|
3.38%
|
1.78%
|
Assets
1 |
5,297
|
5,490
|
2,502
|
4,749
|
4,998
|
8,868
|
Book Value Per Share
2 |
359.0
|
380.0
|
370.0
|
391.0
|
430.0
|
456.0
|
Cash Flow per Share
2 |
205.0
|
103.0
|
119.0
|
175.0
|
220.0
|
176.0
|
Capex
1 |
1,066
|
611
|
323
|
362
|
445
|
229
|
Capex / Sales
|
39.94%
|
20.68%
|
10.85%
|
12.68%
|
14.42%
|
7.73%
|
Announcement Date
|
22/06/18
|
21/06/19
|
24/06/20
|
23/06/21
|
27/06/22
|
22/06/23
|
|
1st Jan change
|
Capi.
|
---|
| -23.02% | 19.35M | | +9.48% | 27.38B | | -30.22% | 3.08B | | -15.44% | 2.51B | | +18.49% | 2.45B | | +7.04% | 2.09B | | -4.11% | 2.05B | | +1.67% | 1.55B | | +0.59% | 1.29B | | +23.78% | 1.23B |
Medical Supplies
|